Merck & Company
News
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Strategic Financial Concepts LLC
Ticker Report Strategic Financial Concepts LLC lifted its position in shares of Merck Co., Inc. (NYSE:MRK - Free Report) by 1,475.6% during the second quarter, according to the company in its most recent...\n more…
Bristol Myers Stock Rises 16% in 3 Months: Buy, Sell or Hold?
Zacks Investment Research Bristol Myers Squibb Company BMY is experiencing a good run of late after touching a 52-week low of $39.35 on July 5. This short rally has given anxious investors a ray of hope. The biotech giant has...\n more…
Merck to Participate in the Bank of America 2024 Global Healthcare Conference
Business Wire Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Joseph Romanelli, president, Human Health International, is scheduled to participate in a fireside chat...\n more…
Merck Announces Positive Top-line Results from Phase 3 Trial Evaluating Efficacy and Safety of GARDASIL9 in Japanese Males
Business Wire Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive top-line results from its pivotal Phase 3 trial (V503-064) evaluating the companys 9-valent Human...\n more…
Is Summit Therapeutics a Buy Now?
Fool.com Headlines Shares of Summit Therapeutics (NASDAQ: SMMT) recently jumped in response to positive clinical trial results for its experimental cancer therapy. Results of the phase 3 Harmoni-2 trial suggest newly...\n more…